AGEN - AGENUS INC
3.24
-0.150 -4.630%
Share volume: 257,048
Last Updated: 03-30-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$3.39
-0.15
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-08-2024 | 11-12-2024 | 03-17-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | 03-16-2026 | |
| Total revenue | 28.005 M | 23.509 M | 25.112 M | 26.837 M | 24.066 M | 25.691 M | 30.235 M | 34.204 M | |
| Cost of revenue | 107.000 K | 115.000 K | 146.000 K | 118.000 K | 137.000 K | 243.000 K | 642.000 K | 0.000 | |
| Gross profit | 27.898 M | 23.394 M | 24.966 M | 26.719 M | 23.929 M | 25.448 M | 29.593 M | 34.204 M | |
| -16.14% | 6.72% | 7.02% | -10.44% | 6.35% | 16.29% | 15.58% | |||
| Operating expenses | 60.780 M | 53.587 M | 58.333 M | 54.706 M | 37.240 M | 42.228 M | 34.456 M | 19.806 M | |
| Selling general and admin | 16.855 M | 16.816 M | 17.275 M | 20.932 M | 15.718 M | 15.518 M | 10.860 M | 12.296 M | |
| Research and development | 43.925 M | 36.771 M | 41.058 M | 33.774 M | 21.522 M | 26.710 M | 23.596 M | 7.510 M | |
| Total expenses | 60.780 M | 53.587 M | 56.470 M | 52.615 M | 37.240 M | 42.159 M | 34.138 M | 19.806 M | |
| -11.83% | 5.38% | -6.83% | -29.22% | 13.21% | -19.03% | -41.98% | |||
| Operating income | -32.882 M | -30.193 M | -31.504 M | -25.896 M | -13.311 M | -16.711 M | -4.545 M | 14.398 M | |
| Ebit | -32.882 M | -30.193 M | -31.504 M | -25.896 M | -13.311 M | -16.711 M | -4.545 M | 14.398 M | |
| Pretax income | -62.348 M | -61.938 M | -67.233 M | -46.582 M | -26.106 M | -30.000 M | -17.715 M | -1.621 M | |
| -0.66% | 8.55% | -30.72% | -43.96% | 14.92% | -40.95% | -90.85% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -63.454 M | -54.797 M | -67.214 M | -46.806 M | -26.370 M | -30.012 M | 63.911 M | -10.612 M | |
| 13.64% | -22.66% | 30.36% | 43.66% | -13.81% | 312.95% | -116.60% |